Master's-level translational research scientist with six years of hands-on
experience across academia, government, and industry, supporting
preclinical drug discovery and in vivo pharmacology in immunology,
structural biology, diabetes, ophthalmology, and metabolic disease.
I design and execute in vivo studies β murine transplant and knockout models β
and read out pharmacodynamic responses, biomarker profiles, and disease-relevant
immune activity using multi-parameter flow cytometry and IHC/IF tissue
immunophenotyping. My work sits at the interface where messy biological
data becomes an actionable decision: continue, redesign, or kill.
Before the in vivo work I spent three and a half years in
structural biology β solving 3D peptide structures by 1D/2D NMR,
synthesizing and macrocyclizing the peptides myself, and applying SAR and
pharmacophore mimicry to proteinβprotein interaction targets. It is the
reason I read a therapeutic candidate as a molecule with a mechanism, not
just a dose on a study calendar.
That work is backed by cGLP/cGMP and ISO experience from the manufacturing side
of medical-device development, and by cross-functional collaboration with
principal investigators, veterinarians, and QC/QA teams.
0Peer-reviewed
publications
0ARVO poster
presentations
0Color flow
cytometry panels
0Bench & in vivo
experience